Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery.
Levy
J H
JH
Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA 30322, USA.
D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000990:Antithrombin III / Q000627:therapeutic use; D020152:Antithrombin III Deficiency; D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D024764:Hirudin Therapy; D006629:Hirudins / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D007431:Intraoperative Complications / Q000097:blood / Q000517:prevention & control; D010446:Peptide Fragments / Q000009:adverse effects / Q000627:therapeutic use; D011183:Postoperative Complications / Q000097:blood / Q000517:prevention & control; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013917:Thrombin / Q000378:metabolism; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D014859:Warfarin; D000990:Antithrombin III; D006493:Heparin; D007611:Aprotinin; D013917:Thrombin; C074619:bivalirudin